Literature DB >> 25317456

Hitting the mark.

Michael Eisenstein.   

Abstract

Year:  2014        PMID： 25317456     DOI： 10.1038/nmeth.3090

Source DB:  PubMed          Journal:  Nat Methods        ISSN： 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  3 in total

1.  Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.

Authors:  Cory Smith; Athurva Gore; Wei Yan; Leire Abalde-Atristain; Zhe Li; Chaoxia He; Ying Wang; Robert A Brodsky; Kun Zhang; Linzhao Cheng; Zhaohui Ye
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

2.  Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.

Authors:  Keiichiro Suzuki; Chang Yu; Jing Qu; Mo Li; Xiaotian Yao; Tingting Yuan; April Goebl; Senwei Tang; Ruotong Ren; Emi Aizawa; Fan Zhang; Xiuling Xu; Rupa Devi Soligalla; Feng Chen; Jessica Kim; Na Young Kim; Hsin-Kai Liao; Chris Benner; Concepcion Rodriguez Esteban; Yabin Jin; Guang-Hui Liu; Yingrui Li; Juan Carlos Izpisua Belmonte
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

3.  Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.

Authors:  Adrian Veres; Bridget S Gosis; Qiurong Ding; Ryan Collins; Ashok Ragavendran; Harrison Brand; Serkan Erdin; Chad A Cowan; Michael E Talkowski; Kiran Musunuru
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.